Joaquin Pastor Selected Research

IBL-302

1/2020	Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma.
1/2020	Preclinical evaluation of a novel triple-acting PIM/PI3K/mTOR inhibitor, IBL-302, in breast cancer.
1/2019	Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joaquin Pastor Research Topics

Disease

6	Neoplasms (Cancer) 08/2022 - 06/2011
3	Neuroblastoma 01/2020 - 01/2019
2	Breast Neoplasms (Breast Cancer) 01/2020 - 11/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2019
1	Obesity 11/2016
1	Fatty Liver 04/2015
1	Ataxia Telangiectasia (Louis Bar Syndrome) 06/2011

Drug/Important Bio-Agent (IBA)

5	Phosphotransferases (Kinase)IBA 01/2020 - 06/2011
3	IBL-302IBA 01/2020 - 01/2019
1	Transcription Factors (Transcription Factor)IBA 08/2022
1	Proteins (Proteins, Gene)FDA Link 08/2022
1	Lapatinib (GW572016)FDA Link 01/2020
1	Trastuzumab (Herceptin)FDA Link 01/2020
1	brigatinibIBA 11/2019
1	AZD1208IBA 11/2019
1	Anaplastic Lymphoma KinaseIBA 11/2019
1	ceritinibIBA 11/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	N-Myc Proto-Oncogene ProteinIBA 01/2019
1	Insulin (Novolin)FDA Link 11/2017
1	AlpelisibIBA 11/2017
1	Protein Isoforms (Isoforms)IBA 11/2016
1	Glucose (Dextrose)FDA LinkGeneric 04/2015
1	DNA-Activated Protein KinaseIBA 06/2011
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 06/2011
1	dactolisibIBA 06/2011
1	DNA (Deoxyribonucleic Acid)IBA 06/2011
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 06/2011

Therapy/Procedure

2	Therapeutics 11/2019 - 01/2019
2	Drug Therapy (Chemotherapy) 01/2019 - 06/2011